India’s MedTech Industry Welcomes CDSCO’s Bold Move to Halt Import of Used Medical Devices

Bengaluru (Karnataka) [India], January 23: In a landmark decision, the Central Drugs Standard Control Organisation (CDSCO) has prohibited the import of used and refurbished medical devices in India. This progressive step is a significant milestone in enhancing patient safety, promoting quality healthcare, and fostering the growth of India’s indigenous MedTech manufacturing sector. Dr. Jitendra Sharma, […]

Continue Reading

Nesa Medtech receives CDSCO Manufacturing License, Marking a Milestone in Next Generation Uterine Fibroid Treatment

Bangalore (Karnataka) [India], July 25: Nesa Medtech, a leading medical device startup in women’s health, has announced its flagship product, GYIDE, received a manufacturing license from CDSCO (Central Drugs Standard Control Organization). This approval marks a significant milestone for the company able to offer scarless treatment for uterine fibroids compared to the existing invasive solutions. […]

Continue Reading

Biophore and its subsidiary, Zenara Pharma, receive the first approval for Cannabidiol in India

100% Made-in-India including the active ingredient Manufactured in US FDA and EU-approved facility in India Indicated for the treatment of neuro disorders Delhi NCR (India),  May 16: Biophore India Pharmaceuticals has announced that it has received CDSCO approval for manufacturing and marketing of Cannabidiol active ingredient in India and its subsidiary, Zenara Pharma, has received the approval for the final product, Cannabidiol Oral Solution 100mg/ml, for […]

Continue Reading